Bjøro T, Mørkrid L, Wergeland R, Turter A, Kvistborg A, Sand T, Torjesen P
Hormone Laboratory, Aker University Hospital, Oslo, Norway.
Scand J Clin Lab Invest. 1995 Apr;55(2):139-47. doi: 10.3109/00365519509089606.
Of 605 hyperprolactinaemic sera (prolactin > 1000 mU l-1 determined with PRL DELFIA, Wallac) in the routine diagnostic (PRL was measured in 10,737 sera) 26% had an increased amount of PRL with molecular weight (MW) = 150-170 kD (150-170 kD PRL or bigbig PRL). In a series of serum samples from 660 healthy subjects, only one female with hyperprolactinaemia due to increased 150-170 kD PRL was found. The 150-170 kD PRL constituted less than 1% of the total PRL found in 11 patients with prolactinoma (macroprolactinoma, PRL 8800-500,000 mU l-1). When determined with five different commercially available immunometric assays, the PRL values in the sera with large amounts of 150-170 kD were increased in all sera in four of five assays, although they varied widely. The clinical implications of hyperprolactinaemia due to increased 150-170 kD PRL are still uncertain.
在常规诊断中(对10737份血清进行了泌乳素检测),605份高泌乳素血症血清(采用Wallac公司的PRL DELFIA法测定泌乳素>1000 mU l-1)中,26%含有分子量(MW)为150 - 170 kD的泌乳素量增加(150 - 170 kD泌乳素或大大泌乳素)。在660名健康受试者的一系列血清样本中,仅发现一名女性因150 - 170 kD泌乳素增加而患有高泌乳素血症。150 - 170 kD泌乳素在11例泌乳素瘤患者(大泌乳素瘤,泌乳素8800 - 500000 mU l-1)的总泌乳素中占比不到1%。当采用五种不同的市售免疫测定法进行检测时,在五种测定法中的四种中,所有血清中含有大量150 - 170 kD的血清中的泌乳素值均升高,尽管它们差异很大。由于150 - 170 kD泌乳素增加导致的高泌乳素血症的临床意义仍不确定。